You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 堃博醫療-B(2216.HK)漲逾5% 高盛稱其股價有翻倍潛力
格隆匯 11-02 14:50
格隆匯11月2日丨堃博醫療-B(2216.HK)漲逾5%,報11.6港元創近兩週新高,總市值61億港元。近期,高盛證券發佈關於堃博醫療評級報吿,認為公司具有解決肺部疾病治療中未被滿足需求的潛力,在介入性肺病領域具有全球影響力,首次覆蓋給予“買入”評級,12個月目標價21.51港元。未來,公司營收大幅增長主要看點將來自於由InterVapor、RF-II以及後續更多肺部疾病治療產品帶來的肺部疾病從診斷到治療的跨越。肺部疾病消融治療的手術將帶動相應的耗材銷售,這也將成為公司未來收入大幅增長的引擎動力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account